[{"data":1,"prerenderedAt":135},["ShallowReactive",2],{"naujienos/from-a-laboratory-in-vilnius-to-the-international-space-station-lithuanian-molecules-against-radiation/en":3},{"status":4,"data":5},true,{"image":6,"id":14,"seo":15,"title":12,"date":90,"url":86,"fullUrl":26,"text":91,"excerpt":25,"more":92,"tags":133,"temos":134},{"src":7,"is_svg":8,"ratio":9,"width":10,"height":11,"alt":12,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/04/delta-bio-komandos-vizitas-eka-su-dr-hahn-1-1-3840x2880.jpeg",false,0.75,3840,2880,"From a Laboratory in Vilnius to the International Space Station – Lithuanian Molecules Against Radiation","",6780,{"title":16,"robots":17,"og_locale":23,"og_type":24,"og_title":16,"og_description":25,"og_url":26,"og_site_name":27,"article_publisher":28,"og_image":29,"twitter_card":34,"schema":35,"breadcrumbs":78,"description":13,"language":87},"From a Laboratory in Vilnius to the International Space Station – Lithuanian Molecules Against Radiation - Inovacijų agentūra",{"index":18,"follow":19,"max-snippet":20,"max-image-preview":21,"max-video-preview":22},"index","follow","max-snippet:-1","max-image-preview:large","max-video-preview:-1","en_US","article","Delta Biosciences, a Lithuanian life sciences company developing medical solutions for space, will, together with the European Space Agency (ESA), launch a long-term, almost three-year mission to the International Space Station (ISS) at the beginning of next year. The goal of this mission is to confirm a hypothesis about anti-radiation drugs and radiation-resistant excipients that can extend the shelf life of medications. This will be the first commercial life sciences mission of its kind.","https://www.inovacijuagentura.lt/en/naujiena/from-a-laboratory-in-vilnius-to-the-international-space-station-lithuanian-molecules-against-radiation/","Inovacijų agentūra","https://www.facebook.com/inovacijuagentura",[30],{"width":31,"height":32,"url":7,"type":33},"4032","3024","image/jpeg","summary_large_image",{"@context":36,"@graph":37},"https://schema.org",[38,53,55,65,69],{"@type":39,"@id":26,"url":26,"name":16,"isPartOf":40,"primaryImageOfPage":42,"image":44,"thumbnailUrl":7,"datePublished":45,"breadcrumb":46,"inLanguage":48,"potentialAction":49},"WebPage",{"@id":41},"https://www.inovacijuagentura.lt/en/#website",{"@id":43},"https://www.inovacijuagentura.lt/en/naujiena/from-a-laboratory-in-vilnius-to-the-international-space-station-lithuanian-molecules-against-radiation/#primaryimage",{"@id":43},"2025-04-28T01:56:00+00:00",{"@id":47},"https://www.inovacijuagentura.lt/en/naujiena/from-a-laboratory-in-vilnius-to-the-international-space-station-lithuanian-molecules-against-radiation/#breadcrumb","en-US",[50],{"@type":51,"target":52},"ReadAction",[26],{"@type":54,"inLanguage":48,"@id":43,"url":7,"contentUrl":7,"width":31,"height":32,"caption":12},"ImageObject",{"@type":56,"@id":47,"itemListElement":57},"BreadcrumbList",[58,63],{"@type":59,"position":60,"name":61,"item":62},"ListItem","1","Home","https://www.inovacijuagentura.lt/en/",{"@type":59,"position":64,"name":12},"2",{"@type":66,"@id":41,"url":62,"name":27,"description":13,"publisher":67,"inLanguage":48},"WebSite",{"@id":68},"https://www.inovacijuagentura.lt/en/#organization",{"@type":70,"@id":68,"name":27,"url":62,"logo":71,"image":76,"sameAs":77},"Organization",{"@type":54,"inLanguage":48,"@id":72,"url":73,"contentUrl":73,"width":74,"height":75,"caption":27},"https://www.inovacijuagentura.lt/en/#/schema/logo/image/","https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/ia-logo-main.svg","1886","786",{"@id":72},[28],[79,82,85],{"url":80,"text":61,"id":81},"/en/",7576,{"url":83,"text":84},"/en/news/","News",{"url":86,"text":12,"id":14},"/en/naujiena/from-a-laboratory-in-vilnius-to-the-international-space-station-lithuanian-molecules-against-radiation/",[88],{"url":26,"code":89,"locale":89,"default":8},"en","2025-04-28","\u003Cp>During the mission, data will be collected on how cosmic radiation affects the stability of molecules developed by Delta Biosciences, as well as those nominated by scientific and commercial partners. These anti-radiation molecules could protect astronauts and vital cargo during long space journeys.\u003C/p>\n\u003Cp>"This mission strengthens Lithuania’s ambition to become a leader in high technology and innovation. Such cooperation not only creates high added value but also reinforces Lithuania’s position as an advanced state in the global market. It once again proves that investments in science, talent, and the innovation ecosystem in Lithuania are yielding real results," says Minister of Economy and Innovation, Lukas Savickas.\u003C/p>\n\u003Cp>Delta Biosciences will also share their experience on the synergy between the life sciences and space sectors at Lithuania’s largest space industry event, Vilnius Space Days 2025, on May 6. They will participate in a discussion about Lithuania’s space ambitions. The event will also feature talks and discussions about the challenges and future directions of European space policy, the role of European institutions and national space associations in ensuring Europe’s independence, space capabilities, and the significance of space research for humanity.\u003C/p>\n\u003Cp>\u003Cstrong>A Step Beyond Current Knowledge\u003C/strong>\u003C/p>\n\u003Cp>According to Eglė Elena Šataitė, head of Space Hub LT at Innovation Agency Lithuania , the Delta Biosciences mission is also a sign that Lithuania is strengthening its influence in the space sector and committing to scientific advancement.\u003C/p>\n\u003Cp>"This experiment is a step forward not only for Delta Biosciences but for Lithuania as a spacefaring nation. It demonstrates that Lithuania has the scientific potential, vision, and capabilities to contribute to the most advanced space research. It also confirms that our collaboration with the European Space Agency and the consistent encouragement of industry to seek solutions for space challenges are delivering results important to the global space sector," says Šataitė.\u003C/p>\n\u003Cp>ESA considers this mission a particularly important step toward addressing the stability of pharmaceutical products in extreme environments. According to ESA's Chief Research Scientist, Dr. Angelique Van Ombergen, such studies are essential for the advancement of human spaceflight. It is necessary to constantly push the boundaries of research to ensure astronaut safety and to deepen medical knowledge.\u003C/p>\n\u003Cp>"There have been very few experiments investigating the effects of space environments on drugs. This study will provide the European Space Agency and the broader space community with new knowledge about how we can protect astronauts and extend the shelf life of medications—essential for long-duration missions beyond low Earth orbit," says Dr. Van Ombergen.\u003C/p>\n\u003Cp>Delta Biosciences co-founder Dominykas Milašius takes pride in this mission because it aligns with ESA's aim to create practical scientific solutions that usher in a new era of human exploration.\u003C/p>\n\u003Cp>"Medicines are developed for conditions on Earth – but the usual rules do not apply in space. Radiation, extreme temperatures, and the lack of resupply opportunities pose new challenges for pharmaceuticals. Therefore, we are developing space medicine based on first principles. The space environment provides a unique opportunity to test radiation resistance and long-term efficacy of drugs. The results of the mission will not only benefit astronauts but also cancer patients, emergency response teams, and people in hard-to-reach locations on Earth," shares Milašius.\u003C/p>\n\u003Cp>\u003Cstrong>Challenge: Replacing Expired Medications During Long Missions Will Be Impossible\u003C/strong>\u003C/p>\n\u003Cp>One of the biggest challenges in human space exploration is radiation exposure. Unlike on Earth, where the atmosphere and magnetic field protect us, astronauts in low Earth orbit and beyond are constantly exposed to galactic cosmic rays and solar particle events. These high-energy particles not only pose health risks, increasing the chances of cancer and other diseases, but they also degrade medicines meant to offer protection—sometimes even producing toxic substances previously unrecorded on Earth.\u003C/p>\n\u003Cp>"Space is a harsh environment, and as we prepare for deep space exploration, we must ensure that essential medications remain effective and safe," says ESA’s Head of Biology Research, Dr. Christiane Hahn. "This experiment will provide crucial data on how drugs break down under cosmic radiation, helping to create protective measures to maintain astronaut health during long-term missions."\u003C/p>\n\u003Cp>\u003Cstrong>From Laboratory to Orbit: The Future of Medicines in Deep Space Missions\u003C/strong>\u003C/p>\n\u003Cp>During the experiment, thirty carefully selected molecules will be tested in two different locations aboard the ISS, each with distinct radiation levels. The samples will be returned to Earth every eight months and compared with control samples. In this way, unique molecular degradation profiles under real space conditions will be created.\u003C/p>\n\u003Cp>Drugs with anti-radiation effects are a vital tool in reducing radiation damage, but their long-term stability in space remains little studied.\u003C/p>\n\u003Cp>"We are sending a variety of active substances into the long-term ISS experiment to study how they change under real cosmic radiation. The collected data will help us validate our protective measures and guide the development of other drugs designed for extreme conditions, including remote areas on Earth. Due to the significance of this research, we are inviting renowned radiation and space medicine scientists from Europe, the USA, and Japan to participate," says Milašius.\u003C/p>\n\u003Cp>While intensive preparations for the experiment are underway, Delta Biosciences and its partners are ensuring that every step—from molecule selection to data analysis—is geared toward achieving the highest-quality results. By studying how radiation affects key medications, the team is taking a critical step toward safer space exploration—and opening the door to innovations in space chemistry that can be applied here on Earth.\u003C/p>\n\u003Cp> \u003C/p>\n",[93,102,111,125],{"image":94,"title":97,"url":98,"id":99,"text":100,"temos":101},{"src":95,"is_svg":8,"ratio":96,"alt":97,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/05/kosmoso-memorandumas-su-polsa.jpg",0.6669921875,"Lithuania Strengthens Cooperation with Poland and the United States in the Space Sector: Important Memorandums Signed","/en/naujiena/lithuania-strengthens-cooperation-with-poland-and-the-united-states-in-the-space-sector-important-memorandums-signed/",6748,"Lithuania’s space sector continues to strengthen international partnerships and expand cooperation with key players in the global space industry. Innovation Agency Lithuania has recently signed two significant memorandums of understanding – with the Polish Space Agency (POLSA) and the U.S. space infrastructure company Vast. These agreements open new opportunities for Lithuanian businesses, research institutions, and international projects.",[],{"image":103,"title":106,"url":107,"id":108,"text":109,"temos":110},{"src":104,"is_svg":8,"ratio":105,"alt":106,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/03/shutterstock-2539768243-1.jpg",0.7490234375,"Lithuania Ranks First in Europe in the Global Entrepreneurship Index","/en/naujiena/lithuania-ranks-first-in-europe-in-the-global-entrepreneurship-index/",6892,"The latest Global Entrepreneurship Monitor (GEM) 2025/2026 global report shows that Lithuania is the leading country in Europe in terms of the quality of its entrepreneurial environment and ranks among the world’s strongest economies in this field.",[],{"image":112,"title":114,"url":115,"id":116,"text":117,"temos":118},{"src":113,"is_svg":8,"ratio":96,"alt":114,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2026/01/karolina-urbonaite.jpg","Lithuania’s Startup Ecosystem Surpasses €16.4 Billion in Value: Investments Jump 1.7x in 2025","/en/naujiena/lithuanias-startup-ecosystem-surpasses-e16-4-billion-in-value-investments-jump-1-7x-in-2025/",6999,"The total value of Lithuania’s startup ecosystem reached €16.4 billion in 2025, according to the latest Dealroom report initiated by Startup Lithuania, a division of the Innovation Agency. In just one year, Lithuanian startups attracted €220 million in venture capital investments from 77 unique investors. The ecosystem’s growing maturity was further confirmed earlier this year with the addition of a new unicorn to Lithuania’s startup map — Cast AI.",[119,122],{"id":120,"name":121},577,"Growth",{"id":123,"name":124},579,"Innovation",{"image":126,"title":128,"url":129,"id":130,"text":131,"temos":132},{"src":127,"is_svg":8,"ratio":96,"alt":128,"caption":13},"https://web-prod.inovacijuagentura.lt/wp-content/uploads/2025/12/modix-fgf-3d-spausdintuvas-2.jpg","Mission-Driven Innovations: Science and Business Shaping Lithuania’s Future","/en/naujiena/mission-driven-innovations-science-and-business-shaping-lithuanias-future/",6904,"Some important scientific research activities and innovative business-developed products may sound complex – unsurprisingly, as they are developed by people who dedicate their entire lives to these fields. Yet behind these sophisticated terms lie concrete solutions that will eventually make each of our daily lives easier. Where science and business join forces, more accurate disease diagnostics for the health of us and our loved ones are developed, cybersecurity tools are created to protect the country, and climate-neutral production technologies and materials emerge to help preserve our nature and resources.",[],[],[],1780325202317]